The Conversation (0)
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
- UBS Global Healthcare Conference on Monday, November 10 at 11:00 AM Eastern Time
- Jefferies Global Healthcare Conference in London on Wednesday, November 19 at 2:00 PM Greenwich Mean Time
- Citi's Global Healthcare Conference on Tuesday, December 2 at 11:15 AM Eastern Time
- Annual Evercore Healthcare Conference on Wednesday, December 3 at 10:50 AM Eastern Time
The live webcasts can be accessed at the company's investors page at investors.gilead.com . The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company's website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251104351900/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
